Blockchain Registration Transaction Record

Creative Biolabs Boosts Oligosaccharide Synthesis and Analysis for Glycan Research

Creative Biolabs enhances oligosaccharide synthesis and analysis for glycan research, offering custom high-purity glycans and advanced characterization via MS, HPLC, and NMR to support therapeutic and vaccine development.

This news matters because structurally defined oligosaccharides are essential for developing next-generation glycan-based therapeutics and vaccines. Creative Biolabs' integrated synthesis and analysis platform reduces technical risks and improves reproducibility, enabling researchers to accelerate discoveries in areas like immunology and targeted drug delivery. By providing reliable glycans, the company supports advancements that could lead to new treatments for diseases involving glycan interactions, directly impacting patient care and biomedical innovation.